ASSAY VALIDATION AND CLINICAL PERFORMANCE OF CHRONIC INFLAMMATORY AND CHEMOKINE BIOMARKERS OF NASH FIBROSIS.

被引：0
|
作者：
Jaycox, S. [1 ]
Kar, S. [2 ]
Paglialunga, S. [1 ]
Islam, R. [2 ]
Paredes, A. [3 ]
机构：
[1] Celerion, Tempe, AZ USA
[2] Celerion, Lincoln, NE USA
[3] San Antonio Mil Med Ctr, Houston, TX USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
E-002
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 50 条
  • [1] Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis
    Kar, Sumit
    Paglialunga, Sabina
    Jaycox, Sharon H.
    Islam, Rafiqul
    Paredes, Angelo H.
    PLOS ONE, 2019, 14 (07):
  • [2] Diagnostic performance of biomarkers for NASH and fibrosis
    不详
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (11): : 972 - 972
  • [3] NASH: Clinical assessment of 501 patients from two separate Academic Medical Centers with validation of a clinical scoring system for advanced hepatic fibrosis.
    Harrison, SA
    Oliver, DA
    Torgerson, S
    Paul, H
    Neuschwander-Tetri, BA
    HEPATOLOGY, 2003, 38 (04) : 511A - 511A
  • [4] Iron deposition in chronic Hepatitis C: Lack of correlation with inflammatory activity and fibrosis.
    Taylor, SL
    Tung, BY
    Emond, MJ
    Kowdley, KV
    HEPATOLOGY, 2000, 32 (04) : 280A - 280A
  • [5] Clinical laboratory performance of the FIBROSpectSM serodiagnostic test for the detection of liver fibrosis.
    Oh, EH
    Nguyen, P
    Mancuso, R
    Smith, KM
    HEPATOLOGY, 2002, 36 (04) : 566A - 566A
  • [6] THE PERFORMANCE OF CLINICAL MODELS TO PREDICT NASH AND ADVANCED FIBROSIS IN OBESITY SURGERY PATIENTS
    Kallwitz, Eric R.
    TenCate, Veronica
    Guzman, Grace
    Vitello, Joseph
    Berkes, Jamie L.
    Layden, Thomas J.
    Cotler, Scott J.
    HEPATOLOGY, 2009, 50 (04) : 795A - 795A
  • [7] Clinical validation of digital biomarkers for paediatric patients with asthma and cystic fibrosis: potential for clinical trials and clinical care
    Kruizinga, Matthijs D.
    Essers, Esmee
    Stuurman, Frederik E.
    Yavuz, Yalcin
    de Kam, Marieke L.
    Zhuparris, Ahnjili
    Janssens, Hettie M.
    Groothuis, Iris
    Sprij, Arwen J.
    Nuijsink, Marianne
    Cohen, Adam F.
    Driessen, Gertjan J. A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (06)
  • [8] Diagnostic performance of noninvasive biomarkers of liver fibrosis and cirrhosis in chronic hepatitis B
    Sebastiani, G.
    Vario, A.
    Noventa, F.
    Guido, M.
    Pistis, R.
    Ferrari, A.
    Alberti, A.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S176 - S176
  • [9] IgG subclasses and chronic bacterial infection. Subclass antibodies and the clinical course of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Pressler, T
    APMIS, 1996, 104 : 1 - +
  • [10] IMPACT ON INFLAMMATORY BIOMARKERS, LIPIDS, AND CARDIOVASCULAR SAFETY OF CENICRIVIROC WITH OR WITHOUT STATINS IN SUBJECTS WITH NASH AND SIGNIFICANT LIVER FIBROSIS: CENTAUR STUDY
    Kowdley, Kris V.
    Alazawi, William
    Lanthier, Nicolas
    Iacob, Alexandru
    Torstenson, Richard
    Seyedkazemi, Star
    Rodriguez-Araujo, Gerardo
    Abdelmalek, Manal F.
    Sanyal, Arun J.
    HEPATOLOGY, 2020, 72 : 1050 - 1051
12345